Furthermore, it was demonstrated that up-regulation of the SPON2/GPR48/LGR4 pathway plays a crucial role in promoting tumor aggressiveness in thyroid cancer through the facilitation of ERK phosphorylation. The gene discussed is LGR4; the disease is thyroid gland carcinoma.